ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate
Clinical trial NCT03898128 · COMPLETED
Trial details
- NCT number
- NCT03898128
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-27
- Primary completion
- 2021-09-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.